Live Q&A

Live Q&A

Live Q&A

Friday 11th September 2020

The Sickle Cell Society’s third Coronavirus (COVID-19) and Sickle Cell Live Q&A took place on: Friday 11th September, 4pm-5pm

It was attended by people from across the country who asked questions around sickle cell and coronavirus to our expert panel and saw presentations on clinical, patient and research perspectives.

Agenda:

  • Clinical Experience Perspective – Keisha Osmond-Joseph (view at 3:09)
  • Experience of Shielding and coming out of lockdown – Zainab Garba- Sani (view at 19:26)
  • UCL Covid-19 Research Study – Professor Fenella Kirkham & Anna Hood, Ph.D (view at 33:48)
  • Question & Answer Session (view at 45:15)

The Q&A panel consisted of:

  • John James OBE (Chief Executive of the Sickle Cell Society)
  • Professor David Rees (Consultant Paediatric Haematologist and SCS Medical Adviser)
  • Dr Kofi Anie (Consultant Psychologist and SCS Medical Adviser)

Watch all the presentations and the full Q&A below:

Friday 5th June 2020

The Sickle Cell Society’s second Coronavirus (COVID-19) and Sickle Cell Live Q&A took place on Friday 5th June 2020 at 4pm-5pm.

The panel consisted of John James OBE (Chief Executive of the Sickle Cell Society), June Okochi (Head Of Program Management at NHS West Essex CCG, and Lead Mentor of SCS Mentoring Programme), Professor David Rees (Consultant Paediatric Haematologist and SCS Medical Adviser), Dr Kofi Anie (Consultant Psychologist and SCS Scientific Adviser), and Dr Mark Layton (Consultant haematologist and SCS Medical Adviser)

Watch the full Q&A below:

Friday 15th May 2020

The Sickle Cell Society’s first Coronavirus (COVID-19) and Sickle Cell Live Q&A took place on Friday 15th May 2020 at 3pm-4pm. It was attended by people from across the country who asked questions around sickle cell and coronavirus to our expert panel.

The panel consisted of John James OBE (Chief Executive of the Sickle Cell Society) and June Okochi (Head Of Program Management at NHS West Essex CCG, and Lead Mentor of SCS Mentoring Programme).

Unfortunately we had some technical issues so other panel members Professor David Rees (Consultant Paediatric Haematologist and SCS Medical Adviser) and Dr Kofi Anie (Consultant Psychologist and SCS Medical Adviser) were not able to join us.

Watch the full Q&A below:

Just to clarify, at the beginning of the video when we talk about shielding letters, we mean that all patients with a sickle cell disorder (e.g. HbSS, HbS Beta thalassaemia, HbSC, HbSD, HbSO) should shield. However, those with sickle cell trait do not need to shield and should follow the guidance given to the general public. Find out more about this here: www.sicklecellsociety.org/coronavirus-and-scd/

Got a Question?

If you have a question surrounding Coronavirus (COVID-19) & Sickle Cell Disorder then submit it for our upcoming Live Q&A (Date TBC) here:

Please note that we will try to answer these questions during our Q&A but may not be able to get to all of them. If your question doesn’t get answered or you have a more pressing question, then please get in touch with our Helpline here: www.sicklecellsociety.org/helpline/


Not used Microsoft Teams before? Click here to download our short guide